BioLattice Ophthalmics, Inc. is addressing the need for tissue repair solutions, beginning with cornea.

One in 70 patients who need cornea tissue obtain it. Globally 2 million per year suffer from corneal blindness while only 200,000 per year receive vision restoration via cornea transplant. 

Almost 13 million globally are on a donor cornea tissue waiting list. There is currently no standard of care alternative to donor cornea tissue for full thickness cornea transplant material. 

Our engineered cornea will be a true alternative to donor cornea while also offering corrective vision. 

Contact

Website: https://biolatticetech.com/
LinkedIn: https://www.linkedin.com/company/biolattice/